Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study
Amir Zarrinpar, Shakti Gupta, Mano R. Maurya, et al.
Gut (2015) Vol. 65, Iss. 9, pp. 1546-1554
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair M. Younossi, Quentin M. Anstee, M. Marietti, et al.
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 15, Iss. 1, pp. 11-20
Closed Access | Times Cited: 4460
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1250
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba, Victor Seguritan, Weizhong Li, et al.
Cell Metabolism (2017) Vol. 25, Iss. 5, pp. 1054-1062.e5
Open Access | Times Cited: 919
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam, Luca Valenti, Stefano Romeo
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 268-279
Closed Access | Times Cited: 837
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, et al.
Digestive and Liver Disease (2015) Vol. 47, Iss. 12, pp. 997-1006
Open Access | Times Cited: 414
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Zobair M. Younossi, Rohit Loomba, Quentin M. Anstee, et al.
Hepatology (2017) Vol. 68, Iss. 1, pp. 349-360
Open Access | Times Cited: 364
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study
Rohit Loomba, Nicholas J. Schork, Chi‐Hua Chen, et al.
Gastroenterology (2015) Vol. 149, Iss. 7, pp. 1784-1793
Open Access | Times Cited: 351
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
Cyrielle Caussy, Mosab H. Alquiraish, Phirum Nguyen, et al.
Hepatology (2017) Vol. 67, Iss. 4, pp. 1348-1359
Open Access | Times Cited: 304
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Jeffrey Cui, Len Philo, Phirum Nguyen, et al.
Journal of Hepatology (2016) Vol. 65, Iss. 2, pp. 369-376
Open Access | Times Cited: 301
Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
Giulio Marchesini, Salvatore Petta, Riccardo Dalle Grave
Hepatology (2015) Vol. 63, Iss. 6, pp. 2032-2043
Open Access | Times Cited: 275
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Cyrielle Caussy, Anupriya Tripathi, Greg Humphrey, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 272
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Tae Gyu Oh, Susy M. Kim, Cyrielle Caussy, et al.
Cell Metabolism (2020) Vol. 32, Iss. 5, pp. 878-888.e6
Open Access | Times Cited: 242
Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study
Rohit Loomba, Jeffrey Cui, Tanya Wolfson, et al.
The American Journal of Gastroenterology (2016) Vol. 111, Iss. 7, pp. 986-994
Open Access | Times Cited: 189
Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy‐proven nonalcoholic fatty liver disease: A prospective study
Jeffrey Cui, Elhamy Heba, Carolyn Hernandez, et al.
Hepatology (2015) Vol. 63, Iss. 2, pp. 453-461
Open Access | Times Cited: 182
Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD
Cyrielle Caussy, Cynthia L. Hsu, Min‐Tzu Lo, et al.
Hepatology (2018) Vol. 68, Iss. 3, pp. 918-932
Open Access | Times Cited: 178
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 52
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
Cyrielle Caussy, Meera Soni, Jeffrey Cui, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 7, pp. 2697-2704
Open Access | Times Cited: 155
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Chang‐Hai Liu, Javier Ampuero, Antonio Gil‐Gómez, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 6, pp. 1335-1348
Open Access | Times Cited: 152
Epigenetics in liver disease: from biology to therapeutics
Timothy Hardy, Derek A. Mann
Gut (2016) Vol. 65, Iss. 11, pp. 1895-1905
Open Access | Times Cited: 148
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
Janki Patel, Ricki Bettencourt, Jeffrey Cui, et al.
Therapeutic Advances in Gastroenterology (2016) Vol. 9, Iss. 5, pp. 692-701
Open Access | Times Cited: 142
miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
Paola Dongiovanni, Marica Meroni, Miriam Longo, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3966-3966
Open Access | Times Cited: 127
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, et al.
Annals of Hepatology (2020) Vol. 19, Iss. 4, pp. 359-366
Open Access | Times Cited: 122
Epigenetics and Liver Fibrosis
Eva Morán‐Salvador, Jelena Mann
Cellular and Molecular Gastroenterology and Hepatology (2017) Vol. 4, Iss. 1, pp. 125-134
Open Access | Times Cited: 115
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
Pierre Bédossa, Keyur Patel
Gastroenterology (2016) Vol. 150, Iss. 8, pp. 1811-1822.e4
Closed Access | Times Cited: 110
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
Jorge Torres, Ignacio Novo‐Veleiro, Laura Manzanedo, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 36, pp. 4104-4118
Open Access | Times Cited: 103
Page 1 - Next Page

Scroll to top